Organigram Global (OGI) Cash & Current Investments (2018 - 2026)
Organigram Global (OGI) reported Cash & Current Investments of $57.9 million for Q1 2026, up 31.39% year-over-year from $44.1 million in Q1 2025, and up 864.21% quarter-over-quarter from $6.0 million in Q4 2025.
Organigram Global (OGI) Cash & Current Investments (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has 9 years of Cash & Current Investments data on file, last reported at $57.9 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $57.9 million, up 31.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $57.9 million (up 31.39% YoY), and the FY2025 annual result was $6.0 million, changed N/A from the prior year.
- Cash & Current Investments rose to $57.9 million in Q1 2026 per OGI's latest filing, from $6.0 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $97.2 million in Q3 2024 and troughed at $6.0 million in Q4 2025.
- A 5-year average of $45.7 million and a median of $41.4 million in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments surged 151.78% in 2024, then sank 92.24% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $23.4 million in 2022, then soared by 65.22% to $38.6 million in 2023, then soared by 100.66% to $77.5 million in 2024, then slumped by 92.24% to $6.0 million in 2025, then soared by 864.21% to $57.9 million in 2026.
- Business Quant data shows OGI's Cash & Current Investments at $57.9 million in Q1 2026, $6.0 million in Q4 2025, and $21.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Organigram Global | 714.36 Mn | 656.41 Mn | 11.96 Mn | 57.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.95 Mn |
| Dec 31, 2025 | 6.01 Mn |
| Sep 30, 2025 | 21.09 Mn |
| Mar 31, 2025 | 44.11 Mn |
| Dec 31, 2024 | 77.47 Mn |
| Sep 30, 2024 | 97.21 Mn |
| Sep 30, 2023 | 38.61 Mn |
| Aug 31, 2022 | 23.37 Mn |
| Nov 30, 2021 | 68.38 Bn |
| Aug 31, 2021 | 103.12 Mn |
| May 31, 2021 | 196.45 Mn |
| Feb 28, 2021 | 71.12 Mn |
| Nov 30, 2020 | 30.00 Bn |
| Aug 31, 2020 | 61.90 Mn |
| May 31, 2020 | 32.02 Mn |
| Feb 29, 2020 | 47.71 Mn |
| Nov 30, 2019 | 34.13 Mn |
| Aug 31, 2019 | 36.26 Mn |
| May 31, 2019 | 41.11 Mn |
| Feb 28, 2019 | 55.06 Mn |